Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Ferris

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of the American Academy of Dermatology|July 26, 2015
Immunosuppression is an independent prognostic factor associated with aggressive tumor behavior in cutaneous melanomaTracy Donahue, Christina Y Lee, Asmi Sanghvi, et al.
Journal of the American Academy of Dermatology|September 22, 2023
Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis RegistryBruce Strober, Laura Ferris, Kristina Callis Duffin, et al.
Dermatology Online Journal|February 23, 2026
31-Gene expression profiling for cutaneous melanoma: an expert consensus panelJoshua Burshtein, Clay Cockerell, David Cotter, et al.
The Journal of Clinical Investigation|February 3, 2011
Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delayMiao He, Lisa E Kratz, Joshua J Michel, et al.
Archives of Dermatology|October 20, 2010
The performance of MelaFind: a prospective multicenter studyGary Monheit, Armand B Cognetta, Laura Ferris, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2023
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept StudyMelinda Gooderham, Leon Kircik, Matthew Zirwas, et al.
Frontiers in Medicine|January 2, 2025
Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomesKyra Diehl, Elizabeth Stoos, Alyssa Becker, et al.
Frontiers in Medicine|March 27, 2026
Correction: Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomesKyra Diehl, Elizabeth Stoos, Alyssa Becker, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of the American Academy of Dermatology|July 26, 2015
Immunosuppression is an independent prognostic factor associated with aggressive tumor behavior in cutaneous melanomaTracy Donahue, Christina Y Lee, Asmi Sanghvi, et al.
Journal of the American Academy of Dermatology|September 22, 2023
Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis RegistryBruce Strober, Laura Ferris, Kristina Callis Duffin, et al.
Dermatology Online Journal|February 23, 2026
31-Gene expression profiling for cutaneous melanoma: an expert consensus panelJoshua Burshtein, Clay Cockerell, David Cotter, et al.
The Journal of Clinical Investigation|February 3, 2011
Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delayMiao He, Lisa E Kratz, Joshua J Michel, et al.
Archives of Dermatology|October 20, 2010
The performance of MelaFind: a prospective multicenter studyGary Monheit, Armand B Cognetta, Laura Ferris, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2023
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept StudyMelinda Gooderham, Leon Kircik, Matthew Zirwas, et al.
Frontiers in Medicine|January 2, 2025
Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomesKyra Diehl, Elizabeth Stoos, Alyssa Becker, et al.
Frontiers in Medicine|March 27, 2026
Correction: Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomesKyra Diehl, Elizabeth Stoos, Alyssa Becker, et al.
Pageof 2